195 related articles for article (PubMed ID: 36087842)
1. A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods.
Wronski ML; Plessow F; Kerem L; Asanza E; O'Donoghue ML; Stanford FC; Bredella MA; Torriani M; Soukas AA; Kheterpal A; Eddy KT; Holmes TM; Deckersbach T; Vangel M; Holsen LM; Lawson EA
Contemp Clin Trials; 2022 Nov; 122():106909. PubMed ID: 36087842
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Oxytocin for Obesity.
Plessow F; Kerem L; Wronski ML; Asanza E; O'Donoghue ML; Stanford FC; Eddy KT; Holmes TM; Misra M; Thomas JJ; Galbiati F; Muhammed M; Sella AC; Hauser K; Smith SE; Holman K; Gydus J; Aulinas A; Vangel M; Healy B; Kheterpal A; Torriani M; Holsen LM; Bredella MA; Lawson EA
NEJM Evid; 2024 May; 3(5):EVIDoa2300349. PubMed ID: 38815173
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Oxytocin Improves Lean Muscle Mass and Lowers LDL Cholesterol in Older Adults with Sarcopenic Obesity: A Pilot Randomized Controlled Trial.
Espinoza SE; Lee JL; Wang CP; Ganapathy V; MacCarthy D; Pascucci C; Musi N; Volpi E
J Am Med Dir Assoc; 2021 Sep; 22(9):1877-1882.e2. PubMed ID: 34029521
[TBL] [Abstract][Full Text] [Related]
5. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin's inhibitory effect on food intake is stronger in obese than normal-weight men.
Thienel M; Fritsche A; Heinrichs M; Peter A; Ewers M; Lehnert H; Born J; Hallschmid M
Int J Obes (Lond); 2016 Nov; 40(11):1707-1714. PubMed ID: 27553712
[TBL] [Abstract][Full Text] [Related]
7. Exenatide has a pronounced effect on energy intake but not energy expenditure in non-diabetic subjects with obesity: A randomized, double-blind, placebo-controlled trial.
Basolo A; Burkholder J; Osgood K; Graham A; Bundrick S; Frankl J; Piaggi P; Thearle MS; Krakoff J
Metabolism; 2018 Aug; 85():116-125. PubMed ID: 29596853
[TBL] [Abstract][Full Text] [Related]
8. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
[TBL] [Abstract][Full Text] [Related]
9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
10. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
Yamasue H; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Owada K; Yassin W; Kushima I; Benner S; Ogawa N; Eriguchi Y; Kawano N; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H
Mol Psychiatry; 2020 Aug; 25(8):1849-1858. PubMed ID: 29955161
[TBL] [Abstract][Full Text] [Related]
11. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin Administration Increases Proactive Control in Men with Overweight or Obesity: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
Plessow F; Marengi DA; Perry SK; Lawson EA
Obesity (Silver Spring); 2021 Jan; 29(1):56-61. PubMed ID: 33225615
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin reduces caloric intake in men.
Lawson EA; Marengi DA; DeSanti RL; Holmes TM; Schoenfeld DA; Tolley CJ
Obesity (Silver Spring); 2015 May; 23(5):950-6. PubMed ID: 25865294
[TBL] [Abstract][Full Text] [Related]
14. OXYTOCIN - AN EMERGING TREATMENT FOR OBESITY AND DYSGLYCEMIA: REVIEW OF RANDOMIZED CONTROLLED TRIALS AND COHORT STUDIES.
Barengolts E
Endocr Pract; 2016 Jul; 22(7):885-94. PubMed ID: 27018619
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin's effect on resting-state functional connectivity varies by age and sex.
Ebner NC; Chen H; Porges E; Lin T; Fischer H; Feifel D; Cohen RA
Psychoneuroendocrinology; 2016 Jul; 69():50-9. PubMed ID: 27032063
[TBL] [Abstract][Full Text] [Related]
16. At the Head and Heart of Oxytocin's Stress-Regulatory Neural and Cardiac Effects: A Chronic Administration RCT in Children with Autism.
Alaerts K; Daniels N; Moerkerke M; Evenepoel M; Tang T; Van der Donck S; Chubar V; Claes S; Steyaert J; Boets B; Prinsen J
Psychother Psychosom; 2023; 92(5):315-328. PubMed ID: 37820592
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
18. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
Kato Y; Kuwabara H; Okada T; Munesue T; Benner S; Kuroda M; Kojima M; Yassin W; Eriguchi Y; Kameno Y; Murayama C; Nishimura T; Tsuchiya K; Kasai K; Ozaki N; Kosaka H; Yamasue H
Mol Autism; 2021 Feb; 12(1):15. PubMed ID: 33622389
[TBL] [Abstract][Full Text] [Related]
19. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.
Tremblay A; Chaput JP; Bérubé-Parent S; Prud'homme D; Leblanc C; Alméras N; Després JP
Eur J Clin Pharmacol; 2007 Feb; 63(2):123-34. PubMed ID: 17200837
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
O'Neil PM; Birkenfeld AL; McGowan B; Mosenzon O; Pedersen SD; Wharton S; Carson CG; Jepsen CH; Kabisch M; Wilding JPH
Lancet; 2018 Aug; 392(10148):637-649. PubMed ID: 30122305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
